You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

afuresertib

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, NSCLC, Cervical Cancer Trial in China (Afuresertib, Nab paclitaxel, Docetaxel)

Recruiting
  • Solid Tumor
  • +5 more
  • Afuresertib
  • +3 more
  • Beijing, Beijing, China
  • +4 more
Jul 15, 2022

Breast Cancer Trial in China, United States (Afuresertib)

Recruiting
  • Breast Cancer
  • Afuresertib
  • Santa Monica, California
  • +11 more
Nov 30, 2022

Tumors, Haematologic Trial in Japan (Afuresertib)

Terminated
  • Neoplasms, Haematologic
  • Afuresertib
  • Aichi, Japan
  • +4 more
Aug 3, 2021

Cancer Trial in Seoul, Taipei (Afuresertib, Paclitaxel)

Completed
  • Cancer
  • Seoul, Korea, Republic of
  • +4 more
Apr 7, 2017

Cancer Trial (Afuresertib, Enzalutamide, Abiraterone)

Withdrawn
  • Cancer
  • Afuresertib
  • +3 more
  • (no location specified)
Oct 5, 2016

Cancer Trial in Cary (Afuresertib, Carfilzomib)

Terminated
  • Cancer
  • Cary, North Carolina
    Novartis Investigative Site
May 3, 2016